HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1966741Generated: October 31, 2026
5-[1-tert-Butyl-2-(2-1,2,4-triazol-1-yl-phenyl)-1H-benzimidazol-5-yl]-4-methoxy-pyrimidin-2-ylamine → 2-Amino-5-[1-tert-butyl-2-(2-1,2,4-triazol-1-yl-phenyl)-1H-benzimidazol-5-yl]-3H-pyrimidin-4-one
https://huagongshe.com/reaction/1966741
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 5-[1-tert-Butyl-2-(2-1,2,4-triazol-1-yl-phenyl)-1H-benzimidazol-5-yl]-4-methoxy-pyrimidin-2-ylamine | HCID 58541993 | — |
| Solvent | Hydrogen Bromide | HCID 260 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | 2-Amino-5-[1-tert-butyl-2-(2-1,2,4-triazol-1-yl-phenyl)-1H-benzimidazol-5-yl]-3H-pyrimidin-4-one | HCID 58542010 | 68% |
Reaction Steps
To a vial are added 5-[1-tert-butyl-2-(2-1,2,4-triazol-1-yl-phenyl)-1H-benzimidazol-5-yl]-4-methoxy-pyrimidin-2-ylamine (Example 44) (47 mg, 0.107 mmol) in THF (2 mL) and HBr (1 mL). The reaction mixture is stirred at 70° C. for 12 hours. The solvent is concentrated. The residue is purified by prep HPLC, with 5-95% acetonitrile/water as gradient to afford the title compound (31 mg, 68%) as a white-gray glass solid. LCMS (ESMS): m/z 427.72 (M++1)
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08420655B2 |
|---|
| Source dataset | uspto-grants-2013_04 |
|---|
| ORD ID | ord-8598583c27b84662a2b4175c4af93d3a |
|---|
| Source note | uspto-grants-2013_04 |
|---|